Insights

Global Market Reach Krka sells its products in over 70 countries, indicating significant international market penetration and potential for expanding distribution channels or partnering with local healthcare providers.

Strategic Innovation The company's focus on developing innovative generic medicines with added value presents opportunities to collaborate on R&D projects or supply high-quality APIs to enhance their product pipeline.

Sustainable Growth Krka’s long-standing 70-year history and steady revenue of approximately 10 billion dollars highlight its stability and growth potential, making it an attractive partner for joint ventures or market expansion initiatives.

Emphasis on Quality Krka’s commitment to high quality, safety, and efficacy across its portfolio offers opportunities to co-develop or supply premium ingredients and complement their product offerings with innovative healthcare solutions.

Technology Adoption Utilizing advanced tech stacks and global distribution centers signals Krka’s openness to digital partnerships, process automation, and supply chain optimization collaborations that can improve efficiency and reach.

KRKA Tech Stack

KRKA uses 8 technology products and services including Microsoft Dynamics NAV, Apple iCloud Mail, Dell, and more. Explore KRKA's tech stack below.

  • Microsoft Dynamics NAV
    Accounting
  • Apple iCloud Mail
    Email
  • Dell
    IT Infrastructure
  • LinkedIn
    Online Community Software
  • iOS
    Programming Languages
  • HSTS
    Security
  • Adobe XD
    Team Collaboration
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

KRKA's Email Address Formats

KRKA uses at least 1 format(s):
KRKA Email FormatsExamplePercentage
First.Last@krka.bizJohn.Doe@krka.biz
97%
Last.First@krka.bizDoe.John@krka.biz
2%
First.Middle@krka.bizJohn.Michael@krka.biz
1%

Frequently Asked Questions

What is KRKA's stock symbol?

Minus sign iconPlus sign icon
KRKA is a publicly traded company; the company's stock symbol is KRK.WA.

What is KRKA's official website and social media links?

Minus sign iconPlus sign icon
KRKA's official website is krka.biz and has social profiles on LinkedIn.

How much revenue does KRKA generate?

Minus sign iconPlus sign icon
As of December 2025, KRKA's annual revenue is estimated to be $5B.

What is KRKA's SIC code NAICS code?

Minus sign iconPlus sign icon
KRKA's SIC code is 2389 - Apparel and Accessories, Not Elsewhere Classified NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does KRKA have currently?

Minus sign iconPlus sign icon
As of December 2025, KRKA has approximately 10K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Financial Officer - At Krka Romania Srl: I. D. L.Chief Accountant: O. G.President And Chief Executive Officer: J. C.. Explore KRKA's employee directory with LeadIQ.

What industry does KRKA belong to?

Minus sign iconPlus sign icon
KRKA operates in the Pharmaceutical Manufacturing industry.

What technology does KRKA use?

Minus sign iconPlus sign icon
KRKA's tech stack includes Microsoft Dynamics NAVApple iCloud MailDellLinkedIniOSHSTSAdobe XDX-Content-Type-Options.

What is KRKA's email format?

Minus sign iconPlus sign icon
KRKA's email format typically follows the pattern of First.Last@krka.biz. Find more KRKA email formats with LeadIQ.

When was KRKA founded?

Minus sign iconPlus sign icon
KRKA was founded in 1954.

KRKA

Pharmaceutical ManufacturingNovo Mesto, Slovenia10001+ Employees

Krka is one of the leading generic pharmaceutical companies in the world.  We have now been successfully implementing our strategies and pursuing our mission and vision for 70 years. Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company’s activities are supplemented by health resort and tourist services. Our products are sold in over 70 countries. 

At Krka we develop innovative generic medicines, i.e. value-added generic medicines that are the product of our own in-house knowledge, and provide our products with major advantages for years after market entry. All our pharmaceuticals offer high quality, efficacy and safety. Our products are marketed under our own brands. 

As a generic producer, Krka produces medicines that can take their place alongside the world’s leading pharmaceutical companies in terms of quality, safety and efficacy. Quality, in the broadest sense of the word, is created, maintained and the responsibility of all employees. Krka’s systematic approach is intended to ensure it exceeds customer requirements and achieve the company’s set operating objectives.

Krka's strategy for own-brand generic pharmaceutical development is achieved through investment in research and development capacity and Krka's own production and distribution centres around the world. Krka’s business performance is based on the commitment and the knowledge of its employees. At Krka we are committed to acquiring, motivating and retaining dedicated and capable staff and building an international corporate culture. Investment in knowledge and the development of all our employees helps them to become among the very best in their own fields of work.

For more information visit www.krka.biz.

Section iconCompany Overview

Website
krka.biz
SIC Code
2389 - Apparel and Accessories, Not Elsewhere Classified
Stock Symbol
KRK.WA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1954
Employees
10001+

Section iconMedia & News

Section iconFunding & Financials

  • $10B

    KRKA's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $10B

    KRKA's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.